Literature DB >> 9345089

Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17.

J R Murrell1, D Koller, T Foroud, M Goedert, M G Spillantini, H J Edenberg, M R Farlow, B Ghetti.   

Abstract

An autosomal dominant presenile dementia affecting 39 individuals in a seven-generation, 383-member pedigree has been studied at Indiana University. In the affected members of this family, clinical symptoms occurred early in life, with an average age at onset of 48.8 years. The presenting clinical features include disequilibrium, neck stiffness, dysphagia, and memory loss. As the disease progresses, further cognitive decline, superior-gaze palsy, and dystaxia also are observed. The average duration from onset of symptoms to death is approximately 10 years. Neuropathologic studies of nine affected individuals showed neuronal loss in several areas of the CNS, as well as argentophilic tau-immunopositive inclusions in neurons and in oligodendroglia. A limited genomic screen by use of DNA samples from 28 family members localized the gene for this disorder to a 3-cM region on chromosome 17, between the markers THRA1 and D17S791. The gene for tau also was analyzed, through samples from the family.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9345089      PMCID: PMC1716034          DOI: 10.1086/301594

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

2.  A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy.

Authors:  W C Nichols; R E Gregg; H B Brewer; M D Benson
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

3.  Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments.

Authors:  M G Spillantini; M Goedert; R A Crowther; J R Murrell; M R Farlow; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  A radiation hybrid map of the BRCA1 region of chromosome 17q12-q21.

Authors:  K J Abel; M Boehnke; M Prahalad; P Ho; W L Flejter; M Watkins; J VanderStoep; S C Chandrasekharappa; F S Collins; T W Glover
Journal:  Genomics       Date:  1993-09       Impact factor: 5.736

5.  Avoiding recomputation in linkage analysis.

Authors:  A A Schäffer; S K Gupta; K Shriram; R W Cottingham
Journal:  Hum Hered       Date:  1994 Jul-Aug       Impact factor: 0.444

6.  Spectrum of amyloid beta-protein immunoreactivity in hereditary Alzheimer disease with a guanine to thymine missense change at position 1924 of the APP gene.

Authors:  B Ghetti; J Murrell; M D Benson; M R Farlow
Journal:  Brain Res       Date:  1992-01-31       Impact factor: 3.252

7.  Human glial fibrillary acidic protein: complementary DNA cloning, chromosome localization, and messenger RNA expression in human glioma cell lines of various phenotypes.

Authors:  E Bongcam-Rudloff; M Nistér; C Betsholtz; J L Wang; G Stenman; K Huebner; C M Croce; B Westermark
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

8.  Hereditary Pick's disease: second re-examination of the large family and discussion of other hereditary cases, with particular reference to electroencephalography, a computerized tomography.

Authors:  J J Groen; L J Endtz
Journal:  Brain       Date:  1982-09       Impact factor: 13.501

9.  Isolation of baculovirus-derived secreted and full-length beta-amyloid precursor protein.

Authors:  J Knops; K Johnson-Wood; D B Schenk; S Sinha; I Lieberburg; L McConlogue
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

10.  Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration.

Authors:  Z K Wszolek; R F Pfeiffer; M H Bhatt; R L Schelper; M Cordes; B J Snow; R L Rodnitzky; E C Wolters; F Arwert; D B Calne
Journal:  Ann Neurol       Date:  1992-09       Impact factor: 10.422

View more
  11 in total

Review 1.  Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

Review 2.  Antibody Therapeutics Targeting Aβ and Tau.

Authors:  Gilbert Gallardo; David M Holtzman
Journal:  Cold Spring Harb Perspect Med       Date:  2017-10-03       Impact factor: 6.915

3.  Cerebral hypometabolism and grey matter density in MAPT intron 10 +3 mutation carriers.

Authors:  Kacie D Deters; Shannon L Risacher; Martin R Farlow; Frederick W Unverzagt; David A Kareken; Gary D Hutchins; Karmen K Yoder; Jill R Murrell; Salvatore Spina; Francine Epperson; Sujuan Gao; Andrew J Saykin; Bernardino Ghetti
Journal:  Am J Neurodegener Dis       Date:  2014-12-05

4.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

Authors:  P Rizzu; J C Van Swieten; M Joosse; M Hasegawa; M Stevens; A Tibben; M F Niermeijer; M Hillebrand; R Ravid; B A Oostra; M Goedert; C M van Duijn; P Heutink
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

5.  The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.

Authors:  Salvatore Spina; Martin R Farlow; Frederick W Unverzagt; David A Kareken; Jill R Murrell; Graham Fraser; Francine Epperson; R Anthony Crowther; Maria G Spillantini; Michel Goedert; Bernardino Ghetti
Journal:  Brain       Date:  2007-12-07       Impact factor: 13.501

6.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

7.  Inheritance of frontotemporal dementia.

Authors:  T W Chow; B L Miller; V N Hayashi; D H Geschwind
Journal:  Arch Neurol       Date:  1999-07

Review 8.  Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.

Authors:  B Ghetti; A L Oblak; B F Boeve; K A Johnson; B C Dickerson; M Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

Review 9.  Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude Wischik; Patrick R Hof
Journal:  Biomolecules       Date:  2016-01-06

Review 10.  Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Authors:  Jianhua Zhou; Qingming Yu; Tie Zou
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.